Selecting the right clinical supply partner from the beginning is vital to early phase trial success. But what else should sponsors be looking for when weighing up their options?

To mitigate risk and ensure early phase clinical trial supply chains are built to withstand whatever the future has in store, sponsors must:

• Operate with agility and uncompromised performance
• Be cost-effective and patient-centric to stand the best possible chance of meeting key milestones
• Promote expedited approval, commercialisation and return on investment

Download our latest guide to discover more.